Bvf Inc Ionis Pharmaceuticals Inc Transaction History

Bvf Inc

$3.15 Billion
Q3 2024

A detailed history of Bvf Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bvf Inc holds 1,451,879 shares of IONS stock, worth $55.3 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares

1,451,879

Previous 3,186,376 54.43%

Holding current value

$55.3 Million

Previous $152 Million 61.7%

% of portfolio

1.85%

Previous 4.64%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $69.5 Million - $90 Million	-1,734,497 Reduced 54.43%	1,451,879 $58.2 Million
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $27.6 Million - $36.1 Million	757,763 Added 31.2%	3,186,376 $152 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $68.4 Million - $81.4 Million	-1,576,000 Reduced 39.35%	2,428,613 $123 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $44.6 Million - $54.6 Million	1,158,598 Added 40.71%	4,004,613 $182 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $9.91 Million - $12.4 Million	285,254 Added 11.14%	2,846,015 $117 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $48.3 Million - $59.3 Million	1,438,952 Added 128.27%	2,560,761 $91.5 Million
Q4 2022 Feb 14, 2023	SELL	$37.12 - $46.52 $65 Million - $81.5 Million	-1,751,144 Reduced 60.95%	1,121,809 $42.4 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $58.3 Million - $77.7 Million	1,596,379 Added 125.05%	2,872,953 $127 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $40.5 Million - $54.9 Million	1,276,574 New	1,276,574 $47.3 Million
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $47.1 Million - $64.5 Million	-1,364,461 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $28.5 Million - $37.9 Million	629,406 Added 85.63%	1,364,461 $77.1 Million
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $32.6 Million - $43.3 Million	-687,787 Reduced 48.34%	735,055 $34.9 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $24.4 Million - $31.8 Million	-521,675 Reduced 26.83%	1,422,842 $83.9 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $9.79 Million - $14.9 Million	-235,218 Reduced 10.79%	1,944,517 $91.9 Million
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $67 Million - $81.2 Million	1,244,187 Added 132.99%	2,179,735 $132 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $55.3 Million - $67.5 Million	935,548 New	935,548 $56 Million
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $497,395 - $762,916	-9,399 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $22.1 Million - $30.4 Million	-510,601 Reduced 98.19%	9,399 $508,000
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $2.14 Million - $2.69 Million	-50,000 Reduced 8.77%	520,000 $26.8 Million
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $23.1 Million - $28.9 Million	570,000 New	570,000 $23.8 Million

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.41B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Account